Cargando…

Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report

Herpes zoster (HZ) is a common contagious dermatological condition that results from reactivation of varicella-zoster virus (VZV), which currently could be prevented by vaccination. We describe a rare case of varicella infection reactivation after routine zoster vaccination in an immunocompetent fem...

Descripción completa

Detalles Bibliográficos
Autores principales: Altukhaim, Feras, Mutlaq, May, Alghamdi, Mohammed, Hakami, Salha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979095/
https://www.ncbi.nlm.nih.gov/pubmed/36874700
http://dx.doi.org/10.7759/cureus.34431
_version_ 1784899653079138304
author Altukhaim, Feras
Mutlaq, May
Alghamdi, Mohammed
Hakami, Salha
author_facet Altukhaim, Feras
Mutlaq, May
Alghamdi, Mohammed
Hakami, Salha
author_sort Altukhaim, Feras
collection PubMed
description Herpes zoster (HZ) is a common contagious dermatological condition that results from reactivation of varicella-zoster virus (VZV), which currently could be prevented by vaccination. We describe a rare case of varicella infection reactivation after routine zoster vaccination in an immunocompetent female in her 60s who developed dermatomal pruritic and vesicular rash one week after receiving Shingrix vaccine, along with fever, sweating, headache, and fatigue. The patient was treated as a case of herpes zoster reactivation with a seven days course of acyclovir. She continued to do well on follow-up with no significant complications. Though uncommon, it is important for healthcare providers to recognize this adverse reaction to expedite testing and treatment.
format Online
Article
Text
id pubmed-9979095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99790952023-03-03 Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report Altukhaim, Feras Mutlaq, May Alghamdi, Mohammed Hakami, Salha Cureus Dermatology Herpes zoster (HZ) is a common contagious dermatological condition that results from reactivation of varicella-zoster virus (VZV), which currently could be prevented by vaccination. We describe a rare case of varicella infection reactivation after routine zoster vaccination in an immunocompetent female in her 60s who developed dermatomal pruritic and vesicular rash one week after receiving Shingrix vaccine, along with fever, sweating, headache, and fatigue. The patient was treated as a case of herpes zoster reactivation with a seven days course of acyclovir. She continued to do well on follow-up with no significant complications. Though uncommon, it is important for healthcare providers to recognize this adverse reaction to expedite testing and treatment. Cureus 2023-01-31 /pmc/articles/PMC9979095/ /pubmed/36874700 http://dx.doi.org/10.7759/cureus.34431 Text en Copyright © 2023, Altukhaim et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Altukhaim, Feras
Mutlaq, May
Alghamdi, Mohammed
Hakami, Salha
Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
title Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
title_full Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
title_fullStr Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
title_full_unstemmed Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
title_short Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
title_sort reactivation of herpes zoster after recombinant vaccine (shingrix): a case report
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979095/
https://www.ncbi.nlm.nih.gov/pubmed/36874700
http://dx.doi.org/10.7759/cureus.34431
work_keys_str_mv AT altukhaimferas reactivationofherpeszosterafterrecombinantvaccineshingrixacasereport
AT mutlaqmay reactivationofherpeszosterafterrecombinantvaccineshingrixacasereport
AT alghamdimohammed reactivationofherpeszosterafterrecombinantvaccineshingrixacasereport
AT hakamisalha reactivationofherpeszosterafterrecombinantvaccineshingrixacasereport